Young A: Insulinotropic actions of ex-endin-4 and glucagon-like peptide-1 invivo and in vitro. Metabolism 50:583–589, 2001 11. Egan JM, Clocquet AR, Elahi D: The in- sulinotropic effect of acute exendin-4administered to humans: comparison ofnondiabetic state to type 2 diabetes.J Clin Endocrinol Metab 87:1282–1290,2002 12. Gedulin B, Jodka C, Hoyt J: Exendin-4 (AC2993) decreases glucagon secretionduring hyperglycemic clamps in diabeticfatty Zucker rats (Abstract). Diabetes 48 (Suppl. 1):A199, 1999 13. Jodka C, Gedulin B, Young A: Exendin-4 potently regulates gastric emptying in rats(Abstract). Diabetes 47 (Suppl. 1):403A, 1998 14. Rayner CK, Samsom M, Jones KL, Horow- itz M: Relationships of upper gastrointes-tinal motor and sensory function withglycemic control. Diabetes Care 24:371– 381, 2001 15. Goke R, Fehmann HC, Linn T, Schmidt